VENATICUS AB
Accelerating preclinical drug development through translational expertise and lab services.
Översikt
- 0
- Anställda
- 0 SEK
- Omsättning
- 2004
- Grundat
Nyckelbeslutsfattare
Karin von Wachenfeldt
CEO
Patrik Holmqvist
Board member
Charlott Brunmark
CSO
Per-Ola Önnervik
Head of In Vivo
+1 fler kontakter i Funnelfeedr
Beskrivning
Truly Translational, founded in 2011, operates as a strategic partner in drug development, supported by its subsidiary, Truly Labs, established in 2015. The organization specializes in providing comprehensive preclinical Contract Research Organization (CRO) services alongside expert strategic consul...